Case Report

Successful Treatment of Subfertility in a Female, 8 Years afterMarriage

DOI https://doi.org/10.70302/jpsim.v2i1.2116
Received: 22 Nov 2020 Accepted: 18 Jan 2021 Published Online: 13 Mar 2021

Abstract

How to Cite This Article

Qaisar W, Waseem T, Mahmood S. Successful Treatment of Subfertility in a Female, 8 Years afterMarriage. J Pak Soc Intern Med. 2021;2(1):60–62. doi:10.70302/jpsim.v2i1.2116

⭳ Download PDF

Conflict of Interest

All authors declare no competing interests.

Disclosed in accordance with ICMJE and COPE guidelines.

Funding

No specific funding was received for this research.

Funder information follows the Crossref Funder Registry standard.

References

  1. Unuane D, Tournaye H, Velkeniers B, Poppe K. Endocrine disorders & female infertility. Best Practice Res Clin Endocrinol Metabol. 2011;25(6):861-73.
  2. 2. Molitch ME. Medication-induced hyperprolactinemia. InMayo Clinic Proceedings. Elsevier. 2005;80(8):1050-7.
  3. Pasyechko N, Naumova L, Krytskyy T, Kulchinska V. Successful treatment of a prolactinoma (case report). Georgian Med News. 2019;(287):26-9. PMID: 30958283.
  4. Nammour GM, Ybarra J, Naheedy MH, Romeo JH, Aron DC. Incidental pituitary macroadenoma: a population-based study. AmJ Med Sci. 1997;314(5):287-91.
  5. Ciccarelli E, Camanni F. Diagnosis and drug therapy of prolactinoma. Drugs. 1996;51(6):954-65.
  6. Ionescu O, Vulpoi C, Ungureanu MC, Ionescu D, Zbranca E. Fertility in prolactinomas--considerations concerning some clinical cases. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi. 2001;105(4):806-9.
  7. Duan L, Yan H, Huang M, Zhang Y, Gu F. An economic analysis of bromocriptine versus trans-sphenoidal surgery for the treatment of prolactinoma. J Craniofacial Surg. 2017;28(4):1046-51.
  8. Pasinetti E, Schivardi MR, Falsetti L, Gastaldi A. Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case. Minerva Ginecologica. 1989;41(3):157-60.
  9. Wong A, Eloy JA, Couldwell WT, Liu JK. Update on prolactinomas. Part 2: treatment and management strategies. J Clin Neuroscience. 2015;22(10):1568-74.
  10. Colao A, Di Sarno A, Landi ML, Scavuzzo F, Cappabianca P, Pivonello R, Volpe R, et,al. Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients. J Clin Endocrinol Metabol. 2000;85(6):2247-52.
  11. Molitch ME. Medical treatment of prolactinomas. Endocrinol Metabol Clinics N Am. 1999;28(1):143-69.
  12. Chanson P, Maiter D. Prolactinoma. In The pituitary. 2017; https://doi.org/10.1016/B978-0-12-804169-7.00016-7. doi:10.1016/B978-0-12-804169-7.00016-7

Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.

CC BY CC BY 4.0 This article is published under the Creative Commons Attribution 4.0 International License. May be shared and adapted with attribution. © 2021 Journal of Pakistan Society of Internal Medicine.